Gilead Sciences, Inc.GILDNASDAQ
$0.00+0.00 (+0.00%)
CLOSED
Prev —|Open —|Day —–—|Vol —
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$23.06+6.1%
Net Income/Share
$0.38-91.5%
Operating CF/Share
$8.68+35.4%
Free CF/Share
$8.26+39.0%
Cash/Share
$9.28+59.4%
Book Value/Share
$15.43-15.3%
Tangible Book/Share
$-7.23+24.9%
Equity/Share
$15.50-15.3%
Interest Debt/Share
$22.20+6.9%
Valuation
Market Cap
$115.19B+13.9%
Enterprise Value
$131.91B+9.9%
P/E Ratio
239.97+1244.6%
P/S Ratio
4.01+7.4%
P/OCF Ratio
10.64-15.8%
P/FCF Ratio
11.18-18.0%
P/B Ratio
5.96+34.6%
P/TB Ratio
5.96+34.6%
EV/Sales
4.59+3.7%
EV/EBITDA
29.75+160.2%
Profitability
Earnings Yield
0.42%-92.6%
FCF Yield
8.95%+21.9%
ROE
2.48%-90.0%
ROIC
2.36%-80.0%
Return on Tangible Assets
1.56%-92.5%
Capital Allocation
CapEx/OCF
4.83%-33.9%
CapEx/Revenue
1.82%-15.7%
CapEx/Depreciation
0.19-13.0%
SBC/Revenue
2.90%+2.8%
Balance Sheet
Debt/Equity
1.38+26.3%
Debt/Assets
0.45+12.6%
Net Debt/EBITDA
3.77+109.4%
Current Ratio
1.60+12.0%
Interest Coverage
1.70x-78.9%
Income Quality
22.56+1496.2%
Efficiency
Days Sales Outstanding
56 days-10.6%
Days Payables Outstanding
49 days+57.4%
Days Inventory
100 days-0.5%
Receivables Turnover
6.51x+11.8%
Payables Turnover
7.50x-36.5%
Inventory Turnover
3.66x+0.5%
Special Valuations
Graham Number
$11.59-73.2%
Graham Net-Net
$-19.26+13.3%